Simile

Simile has raised over $200 million at a $2 billion post-money valuation, led by Greenoaks, to support its mission of simulating all eight billion people.

Research and announcements from Simile — validation methodology, papers, customer results, and company news.

CVS Health has used generative agent simulations to help guide decision-making with the support of Simile, the first company to build and bring this technology to market.

The company says simulation goes beyond prediction and reasoning, enabling it to answer more ambitious questions.

The company offers simulations of how real customers respond to a launch, price change, or campaign before shipping. It was built by the Stanford researchers behind generative agents.

Simile AI, Inc. explains how it handles personal information for participants in its surveys and research studies.

How Simile AI, Inc. collects, uses, and protects information about website visitors, customers, and job applicants.

Mirror Particle is building a foundation model that tracks how people’s motivations and behavior change over time, aiming to help brands predict consumer choices and understand why they happen. The San Francisco startup combines client customer data with current events, pop culture, social media, and other sources, emphasizing observed actions over survey responses; it has raised an angel round and says its first venture round is close to closing. In a pilot with a pet food brand, its system found that packaging imagery was not the sales problem: consumers viewed the recognizable brand as mass-market and cheap.

Oct 2026TechCrunchNews article

Simile raises a $200 million Series B at a $2 billion valuation, five months after announcing a $100 million Series A led by Index Ventures. Greenoaks leads the new round, joined by Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition, and CVS Health Ventures, which is also a customer. Simile provides simulated users for marketing and product research, and its founder is Stanford PhD graduate Joon Sung Park.

Jul 2026TechCrunchNews article

Simile announces that it has raised more than $200 million in a Series B round at a $2 billion post-money valuation. Greenoaks and Index Ventures co-led the financing.

Jul 2026SimileNews article

Simile raises more than $200 million in a Series B at a $2 billion post-money valuation. Greenoaks leads the round.

Jul 2026MLQ.aiNews article